Moors & Cabot, Inc. Gossamer Bio, Inc. Transaction History
Moors & Cabot, Inc.
- $1.96 Billion
- Q3 2024
A detailed history of Moors & Cabot, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 10,000 shares of GOSS stock, worth $9,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$9,300
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
109Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$16.8 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$12.4 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.9 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.54 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.49 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $87.4M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...